Stone Christopher Lewis 4
4 · PDL BIOPHARMA, INC. · Filed Dec 19, 2017
Insider Transaction Report
Form 4
Stone Christopher Lewis
VP and General Counsel
Transactions
- Disposition to Issuer
Common stock
2017-12-15−17,959→ 430,787 total
Footnotes (1)
- [F1]Disposition of common stock due to performance criteria not being achieved under equity incentive plans.